Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome

Authors


Address for Correspondence
Chenghao Guo, Department of Pathology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Jinan, Shandong Province, China.
Tel: +86 531 8838 2045; fax: +86 531 8838 2084;
e-mail: chenghaoguo@sdu.edu.cn

Abstract

Background  Growing evidence suggests that protease activated receptors (PARs) are mediators of persistent neuropathic pain, but their possible function as mediators in patients with post infectious irritable bowel syndrome (PI-IBS) remains to be further explored. This article aims to investigate the expression of PAR2 and PAR4 in the colonic mucosa of patients with PI-IBS, focusing on correlation with mast cell activation status.

Methods  A total of 17 normal controls and 23 patients with PI-IBS volunteered the study. The expression and localization of PAR2 and PAR4 were investigated by RT-PCR and immunohistochemistry, and the expression of PAR2 and PAR4 in the mast cells was examined using double-immunofluorescence staining.

Key Results  The immunohistochemical study revealed that epithelial and submucosal cells showed immunoreactivity for both PAR2 and PAR4. Protease activated receptor 4 mRNA expression and immunoreactivity were down-regulated in PI-IBS compared with the control group. Specifically, a reduced immunoreactivity for PAR4 was observed in mast cells of PI-IBS compared with normal controls, whereas there are no significant differences shown in PAR2 between the PI-IBS and the control group. It is also found that the PAR4 immunoreactivity decreases, while the activity of mast cells increases in PI-IBS rather than normal controls.

Conclusions & Inferences  This study outlines the down-regulation of PAR4 in the mast cells of PI-IBS. It could be of considerable interests in understanding the mechanisms involved in the persistent colonic hypersensitivity and their potential role as therapeutic targets for PI-IBS.

Ancillary